{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:40:17Z","timestamp":1766407217286,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jiac.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T02:05:14Z","timestamp":1678500314000},"page":"637-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk factors and pathogen characteristics associated with unfavorable outcomes among adults with pneumococcal meningitis in Japan, 2006 to 2016"],"prefix":"10.1016","volume":"29","author":[{"given":"Satoshi","family":"Iwata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8435-4425","authenticated-orcid":false,"given":"Shigeo","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Takata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Morozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-2477","authenticated-orcid":false,"given":"Kimiko","family":"Ubukata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.03.003_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199301073280104","article-title":"Acute bacterial meningitis in adults. A review of 493 episodes","volume":"328","author":"Durand","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa040845","article-title":"Clinical features and prognostic factors in adults with bacterial meningitis","volume":"351","author":"van de Beek","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/CMR.00070-09","article-title":"Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis","volume":"23","author":"Brouwer","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2023.03.003_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(12)61187-8","article-title":"Effect of vaccines on bacterial meningitis worldwide","volume":"380","author":"McIntyre","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2023.03.003_bib5","article-title":"Community-acquired bacterial meningitis","volume":"2","author":"van de Beek","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jiac.2023.03.003_bib6","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998-2007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales","volume":"51","author":"Pichon","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2023.03.003_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1179\/joc.2008.20.4.478","article-title":"Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study","volume":"20","author":"Lazzarini","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.jiac.2023.03.003_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/joim.13488","article-title":"Bacterial meningitis: aetiology, risk factors, disease trends and severe sequelae during 50 years in Sweden","volume":"292","author":"Block","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2334-5-93","article-title":"Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection","volume":"5","author":"\u00d8stergaard","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/656409","article-title":"Factors associated with the occurrence of hearing loss after pneumococcal meningitis","volume":"51","author":"Wors\u00f8e","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12879-015-0787-1","article-title":"Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany","volume":"15","author":"Im\u00f6hl","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cmi.2019.12.020","article-title":"Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability, and determinants of outcome in a multicentre prospective cohort","volume":"26","author":"Tubiana","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2023.03.003_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s15010-007-7035-6","article-title":"Bacterial meningitis in an urban area: etiologic study and prognostic factors","volume":"35","author":"Santos","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2023.03.003_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in The Netherlands, 2006-14: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1542\/peds.102.5.1087","article-title":"Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use","volume":"102","author":"Arditi","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2023.03.003_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00431-005-0024-9","article-title":"Clinical data and factors associated with poor outcome in pneumococcal meningitis","volume":"165","author":"Casado-Flores","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jiac.2023.03.003_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(05)70288-X","article-title":"Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series","volume":"5","author":"Weisfelt","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jiac.2023.03.003_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/23744235.2017.1285046","article-title":"Risk factors for community-acquired bacterial meningitis","volume":"49","author":"Lundbo","year":"2017","journal-title":"Inf Disp"},{"key":"10.1016\/j.jiac.2023.03.003_bib20","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pgen.0020031","article-title":"Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes","volume":"2","author":"Bentley","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jiac.2023.03.003_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2023.03.003_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00451-21","article-title":"Anatomical site-specific carbohydrate availability impacts Streptococcus pneumoniae virulence and fitness during colonization and disease","volume":"90","author":"Im","year":"2022","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2023.03.003_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.00008-11","article-title":"Pathogenesis and pathophysiology of pneumococcal meningitis","volume":"24","author":"Mook-Kanamori","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2023.03.003_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.jiac.2023.03.003_bib25","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cis971","article-title":"Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children","volume":"56","author":"Muhammad","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2213-2600(14)70032-3","article-title":"Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis","volume":"2","author":"Simonsen","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib31","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib33","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid2407.170721","article-title":"Pneumococcal meningitis in adults after introduction of PCV7 and PCV13, Israel","volume":"24","author":"Regev-Yochay","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib34","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3201\/eid2509.180747","article-title":"Effect of pneumococcal conjugate vaccines on pneumococcal meningitis, England and Wales","volume":"25","author":"Oligbu","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib35","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid2411.180326","article-title":"Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan","volume":"24","author":"Ubukata","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib36","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.vaccine.2019.12.022","article-title":"Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine","volume":"38","author":"Nakano","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2023.03.003_bib37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jiac.2020.11.019","article-title":"Drastic reduction in pneumococcal meningitis in children owing to the introduction of pneumococcal conjugate vaccines: longitudinal analysis from 2002 to 2016 in Japan","volume":"27","author":"Iwata","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.03.003_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jiac.2017.02.014","article-title":"Pediatric bacterial meningitis in Japan, 2013-2015-3-5 years after the wide use of Haemophilus influenza type b and Streptococcus pneumoniae conjugated vaccines","volume":"23","author":"Shinjoh","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.03.003_bib39","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1017\/S0950268820000813","article-title":"Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan","volume":"148","author":"Takeuchi","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2023.03.003_bib40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/INF.0000000000001956","article-title":"Etiology of acute otitis media and characterization of pneumococcal isolates after introduction of 13-valent pneumococcal conjugate vaccine in Japanese children","volume":"37","author":"Ubukata","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2023.03.003_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2169\/internalmedicine.48.1508","article-title":"Hospital-based study of the prognostic factors in adult patients with acute community-acquired bacterial meningitis in Tokyo, Japan","volume":"48","author":"Ishihara","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2023.03.003_bib42","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1038\/s41598-022-06950-w","article-title":"Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan","volume":"12","author":"Chang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2023.03.003_bib43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","article-title":"Assessment of outcome after severe brain damage","volume":"1","author":"Jennett","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2023.03.003_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/mdr.2011.0102","article-title":"Application of the real-time PCR method for genotypic identification of \u03b2-Lactam resistance in isolates from invasive pneumococcal diseases","volume":"18","author":"Chiba","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jiac.2023.03.003_bib45","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.vaccine.2016.07.003","article-title":"Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults","volume":"34","author":"Baxter","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2023.03.003_bib46","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jiac.2021.04.018","article-title":"Multiple comorbidities increase the risk of death from invasive pneumococcal disease under the age of 65 years","volume":"27","author":"Hanada","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.03.003_bib47","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/AAC.48.5.1488-1494.2004","article-title":"Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002","volume":"48","author":"Ubukata","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"year":"2021","series-title":"Japanese society of laboratory medicine (JSLM)","author":"Guidelines for clinical laboratory testing","key":"10.1016\/j.jiac.2023.03.003_bib48"},{"year":"2016","series-title":"Performance standards for antimicrobial susceptibility testing, Clinical and Laboratory Standard Institute (CLSI), document M100-S26","key":"10.1016\/j.jiac.2023.03.003_bib49"},{"key":"10.1016\/j.jiac.2023.03.003_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12879-016-2113-y","article-title":"Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution","volume":"17","author":"Fukusumi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.003_bib51","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1016\/j.vaccine.2022.04.062","article-title":"Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019","volume":"40","author":"Tamura","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2023.03.003_bib52","first-page":"1","article-title":"Community-acquired bacterial meningitis in patients of 80 years and older","author":"van Soest","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jiac.2023.03.003_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10156-009-0670-3","article-title":"Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR","volume":"15","author":"Chiba","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2023.03.003_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12033-012-9534-7","article-title":"A multi-target real-time PCR assay for rapid identification of meningitis-associated microorganisms","volume":"53","author":"Favaro","year":"2013","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.jiac.2023.03.003_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiac.2023.03.003_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02355118","article-title":"Working Group for Penicillin-Resistant S. pneumoniae. In vitro evaluation of the activity of \u03b2-lactams, new quinolones, and other antimicrobial agents against Streptococcus pneumoniae","volume":"2","author":"Ubukata","year":"1996","journal-title":"J Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:05:49Z","timestamp":1761159949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1341321X23000569"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.03.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and pathogen characteristics associated with unfavorable outcomes among adults with pneumococcal meningitis in Japan, 2006 to 2016","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}